BMS-955176

· Bristol Myers Squibb

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for BMS-955176, covering 2017-01-19 to 2018-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults [Phase 2]